Mode
Text Size
Log in / Sign up

Guidelines recommend routine imaging for relatives of patients with non-syndromic thoracic aortic diseaseNew guidelines: Should your family get screened for hidden aortic disease?

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider new NS-TAD guidelines for screening relatives, but note most recommendations are conditional with low certainty evidence.

Co-produced evidence-based guidelines were developed to standardize cascade screening and secondary prevention for people diagnosed with non-syndromic thoracic aortic disease (NS-TAD) and their relatives. The guidelines address 12 research questions, though no studies were identified for 5 of them. The population focus is on patients with NS-TAD and their family members, with the aim of improving systematic care.

The guidelines make a strong recommendation for routine imaging of first-degree relatives of patients with NS-TAD. For other aspects, conditional recommendations are made, including for cascade screening in first- and second-degree relatives, the routine use of combined genetic and imaging for screening, the use of whole exome sequencing over gene panels, the application of Decision Support Tools for shared decision making, and the use of ARBs and Beta Blockers for secondary prevention. No specific effect sizes, absolute numbers, or statistical measures are reported for these recommendations.

Safety and tolerability data for the recommended interventions are not reported. Key limitations include that no studies were identified for 5 of the 12 research questions, and the evidence certainty was low or very low for the conditional recommendations. The guidelines acknowledge that evidence is often extrapolated from studies on syndromic-TAD. In practice, these guidelines aim to provide a framework for care, but clinicians must recognize that most recommendations are conditional and supported by low-certainty evidence, requiring careful clinical judgment in application.

Imagine being diagnosed with a serious condition affecting your heart's main artery, and then wondering if your family members have it too. That's the reality for people with non-syndromic thoracic aortic disease (NS-TAD), where the aorta can weaken and potentially tear. A new set of guidelines, created with input from patients and doctors, aims to bring more clarity to this stressful situation.

The core message is clear: if you have NS-TAD, your parents, siblings, and children should get routine imaging tests to check their aortas. This is a strong recommendation. For other steps—like screening more distant relatives, using genetic testing, or starting certain preventive medications—the guidelines offer conditional advice. This means the experts think these actions could help, but they're less sure because the supporting evidence is weak or missing entirely.

It's important to understand what these guidelines are and aren't. They weren't created from a big new study. Instead, a panel reviewed all existing research and found major gaps—for five out of twelve key questions, they couldn't find any studies at all. Most of their advice is based on 'low' or 'very low' certainty evidence, often borrowed from research on related but different conditions. So, while this is a helpful roadmap for doctors and families, it's a map drawn with many areas still marked 'unknown.'

What this means for you:
Guidelines strongly advise imaging for close relatives of aortic disease patients, but evidence is limited.

Study Details

Study typeGuideline
EvidenceLevel 5
PublishedMar 2026
View Original Abstract ↓
ObjectiveOver 80% of Thoracic Aortic Disease (TAD) is Non-Syndromic (NS-TAD). However, existing evidence-based guidelines on screening, and secondary prevention are extrapolated from studies in Syndromic-TAD. People with NS-TAD experience unwarranted variation in care. We co-produced evidence-based guidelines for NS-TAD with a view to standardising screening and prevention and identifying gaps in knowledge for future research.MethodsUsing a co-production approach, research questions were defined and ranking using a modified Delphi Process. Evidence based treatment guidelines were developed based on systematic literature reviews, evidence synthesis, and consensus, and used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach.ResultsTwelve research questions were selected. Searches screened 7,115 references and identified 121 relevant studies. No studies were identified for 5 questions, so only 7 were subjected to the GRADE synthesis. A strong recommendation was made for routine imaging of all first-degree relatives with NS-TAD. Conditional recommendations with low or very low certainty evidence were made for cascade screening in first- and second-degree relatives, the routine use of combined genetic and imaging for screening, whole exome sequencing over gene panels, and the application of Decision Support Tools to enable shared decision making about cascade screening in families. Research recommendations were made for the comparison of MRI vs. transthoracic echocardiography for cascade screening, and the management of NS-TAD in pregnancy. For secondary prevention, conditional recommendations with low or very low certainty evidence were made for ARBs and Beta Blockers in NS-TAD.ConclusionsCare of people with NS-TAD is guided by Low certainty evidence.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.